Eric Latimer
professor
Psychiatry
McGill University
Canada
Biography
Dr Latimer is Research Scientist at the Douglas Mental Health University Institute and Professor in the Department of Psychiatry. A health economist, his research interests focus on community-based supports for people with severe mental illness, including assertive community treatment and supported employment. He contributes economic evaluations of various interventions for people with mental illness. He has also conducted research on the use of antipsychotic and concomitant medications in Québec. Currently, he is lead investigator for the Montreal site, and lead economist nationally, of the $110 million Chez Soi / At Home research and demonstration study on homelessness and mental illness, which is testing the Housing First approach using nine concurrent trials in five Canadian cities. He has served as consultant to the Québec government as well as research teams in Europe and North America, and is an associate researcher of the Centre national d’excellence en santé mentale. He is an Editor of the Canadian journal, Healthcare Policy. A fellow of CIRANO and the current holder (2012 – 2014) of the J. Armand Bombardier fellowship in the quality of mental health care, he teaches economic evaluation in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University.
Research Interest
Health economics
Publications
-
Changes in the nature and intensity of stress following employment among people with severe mental illness receiving individual placement and support services: an exploratory qualitative study. Besse C, Poremski D, Laliberté V, Latimer E.
-
Costs of services for homeless people with mental illness in 5 Canadian cities: a large prospective follow-up study. Latimer EA, Rabouin D, Cao Z, Ly A, Powell G, Aubry T, Distasio J, Hwang SW, Somers JM,
-
Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. Malla A, Joober R, Iyer S, Norman R, Schmitz N, Brown T, Lutgens D, Jarvis E, Margolese HC, Casacalenda N, Abdel-Baki A, Latimer E, Mustafa S, Abadi S.
